Sales & Marketing

Increasing competition and the loss of patent protection for existing drugs are constantly offsetting the efforts invested in bringing new medicine into the market.

To ensure the integrity of science while raising awareness for new products, pharmaceutical and the fast-growing bio-pharma companies have taken steps to counteract the backlash of criticism against their past marketing strategies. In the light of new regulations and consumer skepticism, executives are now seeking partnerships that can help them create new approaches to marketing drugs.

Managing and raising awareness of existing brand lifecycles is as crucial as the branding of new products. The industry’s main concerns are finding the appropriate communication avenues to reach consumers worldwide, and to create an educational space for physicians and patients that will truly cater to their needs and foster an understanding of disease and the effectiveness of new medicine.

Optimizing Physician Prescribing Productivity
Gary Slatko, Chief Medical Officer, Paragon Rx, explains how to improve effectiveness, safety and performance in the pharmaceutical and biotech industry.
More >>

Using new technologies for marketing to consumers
By John Mack
Using new technologies like the Internet for marketing purposes is a challenge for the pharmaceutical industry.
More >>

Fostering the leaders of the future
As the largest global, neutral forum for the pharmaceutical industry, the Drug Information Association is a hugely valuable resource for its 20,000 plus members.
More >>

The Value of Assessments in Selection and Development
Increasingly, formal assessments are recognized as adding significant value to selection and development systems. This article describes why this is so, and suggests ways organizations can further increase their value.
More >>

RNA Amplification – Preservation of a Precious Archive
Dr. Andrew I. Brooks Associate Professor of Environmental Medicine and Genetics
More >>

The Value of Assessments in Selection and Development
Increasingly, formal assessments are recognized as adding significant value to selection and development systems. This article describes why this is so, and suggests ways organizations can further increase their value.
More >>

Taking pharma forward
To many outside the pharmaceutical industry, the concepts of industry success and meeting patient needs seem incompatible. Billy Tauzin, President and CEO of the Pharmaceutical Research and Manufacturers of America (PhRMA) disagrees.
More >>

Desktop web conferencing and webcasting streaming video
As rapidly as technology advances forward, the economy is dwindling due to increasing costs and market competition, so how do Pharmaceuticals maintain growth while not threatening product quality?
More >>